EMA — authorised 24 May 2022
- Marketing authorisation holder: ACCORD HEALTHCARE S.L.U.
- Status: approved
🇪🇺 Lupron in European Union
EMA authorised Lupron on 24 May 2022
Marketing authorisation
Lupron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Lupron approved in European Union?
Yes. EMA authorised it on 24 May 2022.
Who is the marketing authorisation holder for Lupron in European Union?
ACCORD HEALTHCARE S.L.U. holds the EU marketing authorisation.